Serum Androgens and Prostate-Specific Antigen Levels in Androgenetic Alopecia: Is There a Difference Between Frontal and Vertex Baldness?

December 2017 in “ Journal of The European Academy of Dermatology and Venereology ”

Anna Lis-Święty, Hubert Arasiewicz, Irmina Ranosz-Janicka, Ligia Brzezińska-Wcisło

androgenetic alopecia frontal baldness vertex baldness serum androgen levels prostate-specific antigen dihydrotestosterone testosterone AGA PSA DHT T

TLDR Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The study aimed to investigate the difference in serum androgen levels and prostate-specific antigen (PSA) levels between men with frontal and vertex baldness caused by androgenetic alopecia (AGA). The study found that men with vertex baldness had higher serum levels of dihydrotestosterone (DHT) than those with frontal baldness, but there were no significant differences in serum testosterone (T) or PSA levels between the two groups. The study suggests that higher DHT levels may be associated with vertex baldness, but further research is needed to confirm this finding.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

8 / 8 results

research Study of Gene Expression Alteration in Male Androgenetic Alopecia: Evidence of Predominant Molecular Signaling Pathways

27 citations, April 2017 in “British Journal of Dermatology”

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

research Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

28 citations, September 2014 in “Journal of Clinical Oncology”

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

research Assessment of the Usefulness of Dihydrotestosterone in the Diagnostics of Patients with Androgenetic Alopecia

35 citations, January 2014 in “Postepy Dermatologii I Alergologii”

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

research Androgenetic Alopecia and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis

34 citations, June 2013 in “Journal of The American Academy of Dermatology”

Vertex pattern hair loss linked to higher prostate cancer risk.

research Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men

21 citations, March 2013 in “Cancer Epidemiology, Biomarkers & Prevention”

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

research The Role of Androgen and Androgen Receptor in Skin-Related Disorders

124 citations, July 2012 in “Archives of Dermatological Research”

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

research Male Pattern Baldness and the Risk of Prostate Cancer

38 citations, February 2011 in “Annals of Oncology”

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

research Serum Androgens and Genetic Linkage Analysis in Early Onset Androgenetic Alopecia

32 citations, August 1999 in “Journal of Investigative Dermatology”

Early onset hair loss linked to genetics and androgen levels.

Related Community Posts Join

6 / 1000+ results

community UPDATE: The theory that explains everything. Please help me make this big!

in Research/Science 449 upvotes 3 years ago

Hair loss theory involves 3alpha-hydroxysteroid reductase (3AHD) converting DHT to androstenol. Discussion explores potential treatments and encourages more research.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

community A Different Take on Curing MBP

16 upvotes 5 years ago

Addressing hair loss by focusing on posture, blood flow, and craniofacial development. Methods include improving posture, cardiovascular activity, scalp massages, healthy diet, meditation, using minoxidil, and addressing craniofacial issues.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Finasteride doesn't work for me in 2 years and my bloodtest result just came in.

in Progress Pictures 88 upvotes 1 year ago

A user has been treating hair loss with finasteride for two years without success and is experiencing an itchy scalp with seborrhea. Despite low DHT levels, they are still losing hair, suggesting that DHT might not be the main cause of their hair loss, and they are considering other treatments or causes.

community Interesting article links major MPB theories to western diet (and life-style)

in Research/Science 57 upvotes 1 month ago

Poor diet and lifestyle contribute to male pattern baldness. Treatments like Minoxidil, dietary changes, and lifestyle adjustments may help slow hair loss.

Similar Research

5 / 1000+ results

research Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels

30 citations, January 2008 in “The Aging Male”

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

research 5α-Reductase Type 2 Gene Variant Associations with Prostate Cancer Risk, Circulating Hormone Levels, and Androgenetic Alopecia

57 citations, February 2007 in “International Journal of Cancer”

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Patients With a Large Prostate Show a Higher Prevalence of Androgenetic Alopecia